Profile data is unavailable for this security.
About the company
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The Company operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.
- Revenue in EUR (TTM)--
- Net income in EUR--
- Incorporated1997
- Employees86.00
- LocationMedigene AGLochhamer Strasse 11PLANEGG 82152GermanyDEU
- Phone+49 892000330
- Fax+49 892 000332920
- Websitehttps://www.medigene.de/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxford Biodynamics PLC | 733.32k | -13.20m | 30.10m | 45.00 | -- | 10.13 | -- | 41.04 | -0.0643 | -0.0643 | 0.0035 | 0.008 | 0.0487 | 1.20 | 0.379 | 13,711.11 | -87.64 | -39.72 | -114.28 | -45.52 | 41.49 | -- | -1,800.32 | -1,324.62 | 0.6156 | -87.72 | 0.7873 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
Guard Therapeutics Intrntnl AB (publ) | 0.00 | -7.50m | 30.45m | 6.00 | -- | 5.62 | -- | -- | -8.74 | -8.74 | 0.00 | 5.27 | 0.00 | -- | -- | -- | -75.10 | -69.56 | -91.32 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
Herantis Pharma Oyj | 0.00 | 279.84k | 30.54m | 10.00 | 120.53 | 6.46 | 109.15 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
Poxel SA | 1.55m | -44.24m | 30.67m | 30.00 | -- | -- | -- | 19.84 | -1.44 | -1.44 | 0.0507 | -1.22 | 0.0597 | -- | 5.42 | 30,920.00 | -170.71 | -31.97 | -432.50 | -55.94 | 0.1294 | -- | -2,861.58 | -101.47 | -- | -4.08 | 11.28 | -- | -94.97 | -33.77 | -32.13 | -- | -8.49 | -- |
Urteste SA | 0.00 | -1.28m | 31.52m | -- | -- | 5.12 | -- | -- | -4.21 | -4.21 | 0.00 | 18.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.97 | -- | 0.0263 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
Gensight Biologics SA | 1.27m | -26.22m | 32.90m | 16.00 | -- | -- | -- | 25.97 | -0.5427 | -0.5427 | 0.0269 | -0.4726 | 0.0723 | -- | 2,534.00 | 79,187.50 | -149.52 | -79.44 | -- | -144.54 | -- | -- | -2,069.53 | -1,036.27 | -- | -- | -- | -- | -50.93 | -- | 5.09 | -- | -58.28 | -- |
OptiBiotix Health PLC | 765.41k | -2.42m | 33.18m | 5.00 | -- | 2.93 | -- | 43.34 | -0.023 | -0.023 | 0.0071 | 0.0973 | 0.0615 | 1.77 | 1.31 | 128,800.00 | -19.46 | 16.82 | -19.90 | 17.52 | 49.69 | 53.03 | -316.61 | 183.49 | 6.62 | -4.87 | 0.00 | 100.14 | 40.92 | 4.60 | -178.82 | -- | -- | -- |
Xbrane Biopharma AB | 16.30m | -30.83m | 33.41m | 75.00 | -- | 0.9935 | -- | 2.05 | -1.33 | -1.58 | 0.6978 | 0.2577 | 0.2465 | 1.34 | 332.12 | 2,053,430.00 | -46.63 | -40.98 | -78.01 | -67.24 | 15.43 | -- | -189.18 | -364.40 | 1.43 | -31.13 | 0.3693 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
Arecor Therapeutics PLC | 5.44m | -10.17m | 33.67m | 50.00 | -- | 2.97 | -- | 6.20 | -0.2793 | -0.2793 | 0.1493 | 0.3111 | 0.2462 | -- | 1.33 | 91,460.00 | -46.06 | -- | -60.53 | -- | -- | -- | -187.05 | -- | 2.02 | -- | 0.0343 | -- | 90.30 | -- | 7.62 | -- | -- | -- |
MediGene AG | -100.00bn | -100.00bn | 33.75m | 86.00 | -- | 1.41 | -- | -- | -- | -- | -- | 0.8144 | -- | -- | -- | -- | -- | -22.31 | -- | -25.28 | -- | 90.15 | -- | -123.17 | -- | -- | 0.1228 | -- | -80.69 | -4.89 | -94.20 | -- | -8.12 | -- |
Annexin Pharmaceuticals AB (publ) | 0.00 | -4.47m | 34.02m | 4.00 | -- | 11.06 | -- | -- | -0.1873 | -0.1873 | 0.00 | 0.0676 | 0.00 | -- | -- | 0.00 | -162.59 | -125.42 | -220.41 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
Skinbiotherapeutics PLC | 192.13k | -3.43m | 35.14m | 11.00 | -- | 7.30 | -- | 182.92 | -0.0165 | -0.0165 | 0.0009 | 0.0192 | 0.0522 | 0.8871 | 0.4181 | 14,695.45 | -93.07 | -52.07 | -115.26 | -57.33 | 62.90 | -- | -1,784.70 | -4,694.37 | 6.48 | -379.78 | 0.0259 | -- | 76.65 | -- | -1.52 | -- | 18.00 | -- |
Mendus AB (publ) | 0.00 | -9.14m | 35.54m | 28.00 | -- | 0.531 | -- | -- | -1.59 | -1.59 | 0.00 | 15.57 | 0.00 | -- | -- | 0.00 | -16.09 | -18.84 | -17.35 | -20.21 | -- | -- | -- | -28,474.53 | -- | -150.86 | 0.0348 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
Fermentalg SA | 4.06m | -14.15m | 37.40m | 62.00 | -- | 0.7194 | -- | 9.22 | -0.3176 | -0.3176 | 0.0917 | 0.6033 | 0.0753 | 0.533 | 3.35 | 65,451.61 | -24.63 | -21.94 | -26.79 | -24.71 | 13.21 | 14.73 | -327.08 | -248.95 | 3.53 | -60.94 | 0.3323 | -- | -46.94 | 75.18 | -43.29 | -- | -10.93 | -- |
Lytix Biopharma AS | 335.14k | -7.38m | 37.41m | 10.00 | -- | 7.12 | -- | 111.63 | -2.16 | -2.16 | 0.0981 | 1.26 | 0.0368 | -- | 0.4091 | 399,100.00 | -80.96 | -56.91 | -94.07 | -65.83 | -- | -- | -2,202.36 | -771.78 | -- | -- | 0.0095 | -- | -63.82 | 63.94 | -56.77 | -- | -- | -- |
genOway SA | 20.05m | 1.57m | 37.47m | 133.00 | 22.68 | 2.15 | 9.34 | 1.87 | 0.1782 | 0.1782 | 2.28 | 1.88 | 0.619 | 0.773 | 3.10 | 150,724.70 | 4.84 | 0.2166 | 6.64 | 0.3048 | 95.82 | 94.82 | 7.82 | 0.4177 | 1.95 | 28.11 | 0.3047 | -- | 17.55 | 13.16 | 101.55 | 22.35 | -- | -- |